Published 11 days ago • loading... • Updated 9 days ago

Dexcom COO on 15-day glucose sensor, Type 2 coverage

Summary by medtechdive.com

Jake Leach caught up with MedTech Dive during the ATTD conference to discuss new data on the company’s glucose monitors.

5 Articles

All

Left

Center

Right

medtechdive.com

Center

Dexcom COO on 15-day glucose sensor, Type 2 coverage

Jake Leach caught up with MedTech Dive during the ATTD conference to discuss new data on the company’s glucose monitors.

10 days ago

Read Full Article

MobiHealthNews

Nanowear announces partnership with Dexcom

Cardiometabolic digital diagnostics company Nanowear announced a licensing and data partnership with glucose monitoring specialist Dexcom to integrate glucose data from the Dexcom G7 into its SimpleSense nanotechnology-enabled wearable. Nanowear offers home-based, AI-enabled digital diagnostics for cardiometabolic health. The company's FDA-cleared SimpleSense wearable reads patient vitals, such as respiration rate, heart rate, blood pressure, p…

9 days ago

Read Full Article

Plato. Vertical Search. Ai. | PlatoAiStream. Data Intelligence. Vertical Search. Ai.

Glooko Integrates Abbott’s FreeStyle Libre Onto Platform

Research indicates there were around 537 million people living with diabetes globally in 2021, with the figure projected to rise to over 700 million by 2045. Image credit: Rohane Hamilton via Shutterstock. Abbott’s continuous glucose monitoring (CGM) device, the FreeStyle Libre, has been integrated with Glooko’s digital platform for diabetes management. The integration is available for individuals with type 1 and type 2 diabetes and healthcare s…

10 days ago

Read Full Article

Drug Delivery Business

Glooko, Abbott integrate FreeStyle Libre into diabetes management

Glooko announced today that its platform now supports the Abbott FreeStyle Libre continuous glucose monitoring (CGM) in the U.S. The integration further strengthens Glooko’s commitment to offering a comprehensive, all-in-one solution for managing diabetes. Palo Alto, California-based Glooko’s current platforms enable patients to share diabetes data with healthcare providers. That includes blood glucose readings, insulin doses, food and carbs, ex…

11 days ago

Read Full Article

hitconsultant.net

Glooko Integrates Abbott FreeStyle Libre CGM

What You Should Know: – Glooko, a provider of integrated digital health solutions for diabetes management, has announced a significant expansion of its platform’s capabilities with the integration of Abbott’s FreeStyle Libre continuous glucose monitoring (CGM) systems in the United States. – The newly implemented integration allows individuals with diabetes to seamlessly synchronize data from their FreeStyle Libre CGM systems with other vital …

11 days ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year